InvestorsHub Logo
Post# of 252254
Next 10
Followers 16
Posts 1503
Boards Moderated 0
Alias Born 05/03/2005

Re: None

Tuesday, 11/06/2007 8:22:43 AM

Tuesday, November 06, 2007 8:22:43 AM

Post# of 252254
MNTA enoxaparin denied

first i've heard about immunogenicity concern although i'm admittedly illiterate in the biotech field.

wondering what people's opinions are as to time line to address and whether premarket price level ~$6.70 reduces MNTA to 'opportunity' level for future products (if Yahoo is to be believed, cash value is about $4).

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.